Protalix BioTherapeutics set to join Russell 3000 Index : vi

CARMIEL - Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary... | June 11, 2023

Related Keywords

Brazil , United States , American , Chiesi Farmaceutici , Dror Bashan , Chuck Padala , Pfizer Inc , European Medicines Agency , European Union , Protalix Biotherapeutics Inc , Exchange Commission , Drug Administration , Chief Executive , Private Securities Litigation Reform Act , Medicines Agency , News Publishing ,